related documents
- Does Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease Impact Clinical Management? A Canadian Experience. Conference Paper
- Infliximab-induced psoriasis in pediatric Crohn Disease; Experience of this paradoxical event at a tertiary centre Conference Paper
- Life threatening complications of sulphasalazine therapy in pediatric inflammatory bowel disease Conference Paper
- Validation and Comparison of Algorithms to Identify Adult-Onset Inflammatory Bowel Disease Patients From Within Health Administrative Data Conference Paper